Assenagon Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $127M | Sell |
|
|||||
|
2025
Q2 | $195M | Sell |
|
|||||
|
2025
Q1 | $298M | Sell |
|
|||||
|
2024
Q4 | $314M | Buy |
|
|||||
|
2024
Q3 | $48.6M | Buy |
|
|||||
|
2024
Q2 | $60.6M | Sell |
|
|||||
|
2024
Q1 | $84.7M | Sell |
|
|||||
|
2023
Q4 | $92.2M | Buy |
|
|||||
|
2023
Q3 | $23.7M | Buy |
|
|||||
|
2023
Q2 | $25.6M | Sell |
|
|||||
|
2023
Q1 | $71.7M | Buy |
|
|||||
|
2022
Q4 | $63.4M | Buy |
|
|||||
|
2022
Q3 | $7.54M | Buy |
|
|||||
|
2022
Q2 | $2.49M | Buy |
|
|||||
|
2022
Q1 | $2.8M | Buy |
|
|||||
|
2021
Q4 | $2.98M | Buy |
|
|||||
|
2021
Q3 | $896K | Buy |
|
|||||
|
2021
Q2 | $218K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $909K | Sell |
|
|||||
|
2020
Q2 | $910K | Sell |
|
|||||
|
2020
Q1 | $16.7M | Buy |
|
|||||
|
2019
Q4 | $255K | Sell |
|
|||||
|
2019
Q3 | $2.19M | Sell |
|
|||||
|
2019
Q2 | $40.6M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $2.67M | Sell |
|
|||||
|
2018
Q3 | $29.1M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $1.93M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.25M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $4.37M | Sell |
|
|||||
|
2016
Q4 | $12.6M | Buy |
|